Navigation Links
Cancer patients' quality of life directly relates to their survival
Date:5/16/2008

ROCHESTER, Minn. -- Patients who feel better live longer, say Mayo Clinic researchers, working with the North Central Cancer Treatment Group (NCCTG), in study results released May 15 as part of the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).

Mayo Clinic cancer researcher and the studys lead author, Angelina Tan, says the results show quality of life is an independent factor in survival.

Quality of life appears to affect the survival of cancer patients, says Tan. If physicians can identify patients who are not doing well, they will be able to intervene and, we hope, improve not only their patients sense of well-being, but also their length of life.

The researchers compared overall survival with responses from 3,704 patients to one question -- On a scale of 0 to 10, how would you rate your quality of life? Patients had a variety of cancer types, and the question was asked during their participation in one of 24 different NCCTG clinical trials. The unifying factor for the patients was that all had late-stage disease. All results were converted to a 100-point scale.

The team found that baseline quality of life was a strong predictor of survival. They found a distinct difference when dividing patients by the median score of 83 (6.1 months increased survival time for those with scores greater than or equal to 83). The investigators also divided the group into those with scores of more than 50 and 50 or less, defining those in the 50 or less category as having clinically deficient quality of life. In this analysis, the results were even more striking, with increased survival of 7.5 months for the non-clinically deficient patients. The investigators determined that these numbers were independent of performance status (a traditionally used survival prediction method evaluating a patients ambulatory status).

This study is one of several similar quality of life studies that are being presented by M
'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ls about how proteins used to destroy bacteria and...nar K. Gouras, associate professor of neurology an... University, New York, and colleagues provide new ...alled antibodies, reduce the main hallmarks of Alz...
... scientific method for testing and measuring xanth...nducted on XanGo Juice , indicate usage of the who... high xanthone absorption. XanGo, LLC, recognized...t category is leading scientific exploration of th...
...ng all possible arrangements to look good on her y...o sources, the first thing that the socialite will... dry face. Hilton has resentfully complained to t...that she's not permitted to have facial moisturize...
...y who were destined to go blind within five years ...treatment with Avastin , a well-known cancer drug,...ne, 2007 Archives of Ophthalmology. This is a majo...ts who are treated with radiation therapy and comm...
Other Medicine News:Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:New Technique to Measure Xanthone in Mangosteen 2Health News:New Technique to Measure Xanthone in Mangosteen 3Health News:Untreatable Eye Disease Improves With Avastin 2
(Date:8/25/2008)...t and Japanese Development Studies ...ust 25 /- Genmab has,announ...hronic lymphocytic,leukemia and non-Hodgkin,s lymp...s to begin four studies of,ofatumumab in chronic l...in,s lymphoma (NHL) this year., "Genmab and GSK h...
(Date:8/22/2008)...FirstCall/ -- Human Genome,Sciences, Inc. (Nasdaq:...,enrollment and initial dosing of patients in a ra...n combination with the chemotherapy agents,paclita...ced non-small cell,lung cancer (NSCLC)., (Logo: ...GO ), "There is an urgent medical need for effec...
(Date:8/21/2008)...-USNewswire/ -- Dangerous disease,often spreads fa...emedy,that, researchers at Kansas State University...s down to hours., Sanjeev Narayanan, assistant pr...t, both in the department of diagnostic medicine a... microarray to seek out the,specific genetic marke...
(Date:8/21/2008)...re-FirstCall/ -- Telik, Inc.,(Nasdaq: TELK ) anno...me,inhibitor program met a preclinical development... preclinical models of human leukemia. The proteas...or the growth and function of,cancer cells and inh...e,cell cycle arrest and cancer cell death or apopt...
Breaking Medicine Technology:Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 2Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 3Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 4Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer 5Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2Telik's Proteasome Inhibitor Program Meets a Preclinical Development Milestone 2To catch a panda 1538 1To catch a panda 1538 2Massive dinosaur discovered in Antarctica sheds light on life distribution of sauropodomorphs 1533 1Massive dinosaur discovered in Antarctica sheds light on life distribution of sauropodomorphs 1533 2CRi Announces Nuance 2 the Next Generation Multispectral Imaging System for Brightfield and Fluorescent Based Microscopy 2122 1CRi Announces Nuance 2 the Next Generation Multispectral Imaging System for Brightfield and Fluorescent Based Microscopy 2122 2New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 1New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 2New Report Offers Hope for Closing Health Gap for African Americans With Nearly 700 Medicines in Pipeline 1026 3
...fficacy in broad range,of patients and across cont.../PRNewswire-FirstCall/ --,Millennium Pharmaceutica...e market leading therapy with unsurpassed single-a... multiple myeloma,(MM), will be featured at the up..., Greece, June 25-30, 2007. , "Clinical data to be...
...ll/ -- Vical,Incorporated today announced that the...ive results following interim analysis of data,fro...l of an,angiogenesis product candidate using Vical...that the primary efficacy,endpoint in the trial ha...that there were no major safety concerns related,t...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
...ld, point-of-care device for the qualitative detec...The TOX/See device can detect up to nine of the mo...uires only a few drops of urine. Each TOX/See cass...nce and ease of use. TOX/See features integrated t...
Medicine Products: